J9322 Pemetrexed (Bluepoint) - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Pemetrexed (Bluepoint)

Brand Name:

Pemetrexed (Bluepoint)

Strength:

10mg

HCPCS:

J9322

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimetabolite

Minor Drug Class:

Folic Acid Analog

Oral (Y/N):

No

FDA Approval Year:

2022

FDA Discontinuation Year:

CMS Effective Date:

July 11, 2023

CMS Discontinuation Date:

Status:

In Use